Bundang CHA Hospital Develops Bone-Regeneration Scaffold Powered by Lactic Acid Signaling
When a fracture is severe or involves substantial bone loss, the body's natural regenerative capacity often falls short.
Search results for "platform technology"
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour
Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s obesity drug candidate "EPPE" has...
AI Consortium Launches 7.5 Billion Won Project to Personalize Chronic Pain Rehab for Older Adults
"My knee hurts constantly," an older patient might tell their doctor. Yet in many cases, diagnostic imaging like X-rays...
Regenerative Technique Aims to Solve Rotator Cuff Re-Tears by Rebuilding the Tendon-Bone Junction
When surgeons reattach a torn shoulder tendon to the bone, a frustrating setback often occurs over time: the repair...
Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform,...
Preserving Form and Hope: Korean Surgeon Reaches 500th Robotic Breast Cancer Operation
Patients preparing for breast cancer surgery often ask a quiet question before entering the operating room.
A Single Drop of Plasma and 10 Minutes: Rapid Test Identifies Cardiovascular Disease with 91.4% Accuracy
Researchers have developed a diagnostic technology capable of reading molecular signals associated with cardiovascular...
AbTis Wins U.S. Patent Ruling, Safeguarding Core Rights to AbClick Platform
Antibody-drug conjugate developer AbTis announced on August 14 that it has prevailed in an inter partes review before...
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors
When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...